Lung Cancer
Lung Cancer is a subscription (hybrid open access) journal published by Elsevier BV in the Netherlands. OpenAlex counts 26,004 works from it, cited 366,242 times; its h-index is 192. Its two-year mean citedness, which is computed the way the impact factor is, is 2.8: a paper it published in the two years before was cited about 2.8 times last year. It published 656 papers in 2025, up 36% from 481 in 2024. Publishing a paper open access in it costs about US$3,390.
- Publisher
- Elsevier BV
- Citations per paper
- 2.8 two-year mean, OpenAlex
- h-index
- 192 i10-index 6,736
- Access
- Subscription · hybrid open access
- APC
- US$3,390 to publish open access
- ISSN
- 0169-5002, 1872-8332
- Country
- Netherlands
- Works published
- 26,004 cited 366,242 times
- Papers in 2025
- 656
- Field
- Medicine
- Website
- Journal home ↗
Lung Cancer year by year
Papers it published each year, and the citations all its papers received that year.
| Year | Papers published | Citations received |
|---|---|---|
| 2026 so far | 644 | 15,378 |
| 2025 | 656 | 19,034 |
| 2024 | 481 | 19,385 |
| 2023 | 442 | 20,240 |
| 2022 | 429 | 20,939 |
| 2021 | 522 | 21,785 |
| 2020 | 600 | 19,989 |
| 2019 | 598 | 16,529 |
What Lung Cancer publishes
Its most frequent research topics, by OpenAlex's topic classification.
- Lung Cancer Diagnosis and TreatmentPulmonary and Respiratory Medicine · 17,532 papers
- Lung Cancer Research StudiesOncology · 11,995 papers
- Lung Cancer Treatments and MutationsPulmonary and Respiratory Medicine · 9,323 papers
- Occupational and environmental lung diseasesPulmonary and Respiratory Medicine · 3,018 papers
- Metastasis and carcinoma case studiesPulmonary and Respiratory Medicine · 1,622 papers
Questions about Lung Cancer
What is the impact factor of Lung Cancer?
Clarivate's Journal Impact Factor is licensed and not shown here. OpenAlex's two-year mean citedness, computed the same way from open data, is 2.8 for Lung Cancer: on average, each paper it published in the two years before was cited about 2.8 times in a year.
What is the h-index of Lung Cancer?
192, by OpenAlex's count: 192 of its papers have each been cited at least 192 times. Its i10-index is 6,736.
Is Lung Cancer open access?
Not fully. Lung Cancer is a subscription journal; a paper is free to read when its authors paid for open access or posted a copy in a repository.
What is the publication fee (APC) of Lung Cancer?
About US$3,390, which is the fee to publish a paper open access as listed by OpenAlex. Fees change and waivers exist, so check the journal's own page before you submit.
What is the ISSN of Lung Cancer?
Its linking ISSN is 0169-5002; all its ISSNs: 0169-5002, 1872-8332.
Who publishes Lung Cancer?
Elsevier BV, based in the Netherlands.
How many papers does Lung Cancer publish a year?
656 in 2025, by OpenAlex's count of what it published that year.
What does Lung Cancer publish?
Its most frequent research topics are Lung Cancer Diagnosis and Treatment, Lung Cancer Research Studies, Lung Cancer Treatments and Mutations, in the field of Medicine.
Is Lung Cancer a predatory journal?
Nothing in the scholarly indexes suggests so. Lung Cancer is on OpenAlex's list of core sources, journals with peer review and an editorial board, it has published 26,004 works cited 366,242 times. For a journal you do not know, check the red flags with our predatory journal checker.
Is Lung Cancer indexed in Scopus or Web of Science?
Check the Scopus Sources list and Clarivate's Master Journal List by its ISSN (0169-5002): both are free to search. Our guide on checking journal indexing shows each step.
Journals like Lung Cancer
Other Medicine journals with a similar impact.
Journal data from OpenAlex (CC0), compiled 21 November 2026. Download the whole directory as a CSV file (CC BY 4.0).